Key result
Mokko lactone prevented doxorubicin-induced liver injury in rats by ameliorating transaminase elevations and oxidative stress, partially through the Sirt-1/FOXO1/NF-κB axis.
Why the study?
Doxorubicin causes serious adverse effects including hepatotoxicity, prompting evaluation of the potential protective effects of mokko lactone against doxorubicin-induced hepatotoxicity in rats.
Does Mokko lactone prevent doxorubicin-induced hepatotoxicity in rats?
Population
Rats
Comparison
Mokko lactone against doxorubicin-induced hepatotoxicity
Authors
Loading...
Not ready for clinical use; leaves open translation of rat hepatoprotection to doxorubicin-treated patients.
Does Mokko lactone prevent doxorubicin-induced hepatotoxicity in rats?
Mokko lactone demonstrates protective effects against doxorubicin-induced hepatotoxicity in a rat model, likely mediated through the Sirt-1/FOXO1/NF-κB axis.
Sirwi et al. (2021) studied Doxorubicin-induced hepatotoxicity. Mokko lactone vs. Doxorubicin was evaluated on Hepatotoxicity (serum ALT, AST, ALP and liver histology). Mokko lactone prevented doxorubicin-induced liver injury in rats by ameliorating transaminase elevations and oxidative stress, partially through the Sirt-1/FOXO1/NF-κB axis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: